Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Frontage Holdings's operating assets for the quarter that ended in Dec. 2025 was HK$3,905 Mil. Frontage Holdings's operating liabilities for the quarter that ended in Dec. 2025 was HK$509 Mil. Frontage Holdings's Total Assets for the quarter that ended in Jun. 2025 was HK$4,272 Mil. Therefore, Frontage Holdings's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.80.
Frontage Holdings Scaled Net Operating Assets Related Terms
Frontage Holdings Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Frontage Holdings's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frontage Holdings Scaled Net Operating Assets Chart
HKSE:01521 vs VRTX, REGN, RVMD: Scaled Net Operating Assets Comparison
For the Biotechnology subindustry, Frontage Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frontage Holdings Scaled Net Operating Assets vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Frontage Holdings's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Frontage Holdings's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.80 mean?
Frontage Holdings (HKSE:01521) has a Scaled Net Operating Assets of 0.80 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Frontage Holdings and its competitors.
Is Frontage Holdings' Scaled Net Operating Assets too high?
Frontage Holdings' current Scaled Net Operating Assets is 0.80. Overall, Frontage Holdings has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Frontage Holdings' Scaled Net Operating Assets compare to VRTX and REGN?
Frontage Holdings' Scaled Net Operating Assets of 0.80 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Frontage Holdings and its competitors. Frontage Holdings's current Scaled Net Operating Assets is 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontage Holdings stock overvalued right now?
Based on GuruFocus' analysis, Frontage Holdings (HKSE:01521) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$1.55, compared to a current price of HK$1.26 — trading 18.7% below its estimated fair value. The current Scaled Net Operating Assets is 0.80. Frontage Holdings' overall GF Score™ is 89/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Frontage Holdings (HKSE:01521), the current Scaled Net Operating Assets is 0.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frontage Holdings (HKSE:01521) Overvalued in 2026?
Based on GuruFocus' analysis, Frontage Holdings stock appears to be undervalued.
The current stock price of HK$1.26 is trading 18.7% below its estimated GF Value™ of HK$1.55.
GuruFocus considers Frontage Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:01521:
Scaled Net Operating Assets: 0.80
GF Value™: HK$1.55 vs. price of HK$1.26 (18.7% below fair value)
No single metric tells the full story. See the HKSE:01521 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frontage Holdings Corp provides laboratory and related services to pharmaceutical and agrochemical companies. Its segments include North America and Europe segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the USA, Canada and Europe; and PRC segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the PRC. It derives majority of the revenue from North America and Europe segment. Geographically majority of the revenue is derived from USA and Canada.
89GF Score
Get the complete analysis for HKSE:01521
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01521 has been successfully added to your 
